Craniosynostosis is a condition in which the bones in an infant’s skull grow together too early, causing problems with brain growth and head shape. The edges of the skull bones are called sutures, which normally close by age 2 to 3. With craniosynostosis, the head stops growing in the areas where the sutures have fused, and expands abnormally in other areas.
Treatment goals focus on relieving pressure inside the head, ensuring enough room for the brain to grow, and correcting skull and facial deformities. Surgery is recommended before age 1, while the skull bones are relatively soft. Minimally invasive surgery is for infants younger than 3 months to open skull sutures for normal skull and brain growth. Traditional surgery is better for infants 6 months or older to correct the skull’s shape.
This report provides a complete quantitative data and qualitative analysis on the global market for Pediatric Craniosynostosis Treatment. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Pediatric Craniosynostosis Treatment was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Pediatric Craniosynostosis Treatment is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Pediatric Craniosynostosis Treatment, including the following market information:
Global Pediatric Craniosynostosis Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pediatric Craniosynostosis Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pediatric Craniosynostosis Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pediatric Craniosynostosis Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Arthrex, B. Braun Melsungen, Cogentix Medical, Medtronic, Conmed Corporation, Cook Medical, Johnson & Johnson Services, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Stereotactic Image Guided Endoscopic Craniosynostosis Repair
Standard Craniosynostosis Surgery
Baby Helmet Therapy
Based on the Application:
Hospital
Clinics
Diagnostic Centers
Treatment goals focus on relieving pressure inside the head, ensuring enough room for the brain to grow, and correcting skull and facial deformities. Surgery is recommended before age 1, while the skull bones are relatively soft. Minimally invasive surgery is for infants younger than 3 months to open skull sutures for normal skull and brain growth. Traditional surgery is better for infants 6 months or older to correct the skull’s shape.
This report provides a complete quantitative data and qualitative analysis on the global market for Pediatric Craniosynostosis Treatment. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Pediatric Craniosynostosis Treatment was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Pediatric Craniosynostosis Treatment is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Pediatric Craniosynostosis Treatment, including the following market information:
Global Pediatric Craniosynostosis Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pediatric Craniosynostosis Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pediatric Craniosynostosis Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pediatric Craniosynostosis Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Arthrex, B. Braun Melsungen, Cogentix Medical, Medtronic, Conmed Corporation, Cook Medical, Johnson & Johnson Services, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Stereotactic Image Guided Endoscopic Craniosynostosis Repair
Standard Craniosynostosis Surgery
Baby Helmet Therapy
Based on the Application:
Hospital
Clinics
Diagnostic Centers
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Pediatric Craniosynostosis Treatment Industry
1.7 COVID-19 Impact: Pediatric Craniosynostosis Treatment Market Trends
2 Global Pediatric Craniosynostosis Treatment Quarterly Market Size Analysis
2.1 Pediatric Craniosynostosis Treatment Business Impact Assessment - COVID-19
2.1.1 Global Pediatric Craniosynostosis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Pediatric Craniosynostosis Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Pediatric Craniosynostosis Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Pediatric Craniosynostosis Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Pediatric Craniosynostosis Treatment Market
3.4 Key Players Pediatric Craniosynostosis Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Pediatric Craniosynostosis Treatment Segments, By Type
4.1 Introduction
1.4.1 Stereotactic Image Guided Endoscopic Craniosynostosis Repair
1.4.2 Standard Craniosynostosis Surgery
1.4.3 Baby Helmet Therapy
4.2 By Type, Global Pediatric Craniosynostosis Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Pediatric Craniosynostosis Treatment Segments, By Application
5.1 Overview
5.5.1 Hospital
5.5.2 Clinics
5.5.3 Diagnostic Centers
5.2 By Application, Global Pediatric Craniosynostosis Treatment Market Size, 2019-2021
5.2.1 By Application, Global Pediatric Craniosynostosis Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Arthrex
7.1.1 Arthrex Business Overview
7.1.2 Arthrex Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.1.3 Arthrex Pediatric Craniosynostosis Treatment Product Introduction
7.1.4 Arthrex Response to COVID-19 and Related Developments
7.2 B. Braun Melsungen
7.2.1 B. Braun Melsungen Business Overview
7.2.2 B. Braun Melsungen Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.2.3 B. Braun Melsungen Pediatric Craniosynostosis Treatment Product Introduction
7.2.4 B. Braun Melsungen Response to COVID-19 and Related Developments
7.3 Cogentix Medical
7.3.1 Cogentix Medical Business Overview
7.3.2 Cogentix Medical Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.3.3 Cogentix Medical Pediatric Craniosynostosis Treatment Product Introduction
7.3.4 Cogentix Medical Response to COVID-19 and Related Developments
7.4 Medtronic
7.4.1 Medtronic Business Overview
7.4.2 Medtronic Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.4.3 Medtronic Pediatric Craniosynostosis Treatment Product Introduction
7.4.4 Medtronic Response to COVID-19 and Related Developments
7.5 Conmed Corporation
7.5.1 Conmed Corporation Business Overview
7.5.2 Conmed Corporation Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.5.3 Conmed Corporation Pediatric Craniosynostosis Treatment Product Introduction
7.5.4 Conmed Corporation Response to COVID-19 and Related Developments
7.6 Cook Medical
7.6.1 Cook Medical Business Overview
7.6.2 Cook Medical Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.6.3 Cook Medical Pediatric Craniosynostosis Treatment Product Introduction
7.6.4 Cook Medical Response to COVID-19 and Related Developments
7.7 Johnson & Johnson Services
7.7.1 Johnson & Johnson Services Business Overview
7.7.2 Johnson & Johnson Services Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.7.3 Johnson & Johnson Services Pediatric Craniosynostosis Treatment Product Introduction
7.7.4 Johnson & Johnson Services Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Pediatric Craniosynostosis Treatment Industry
1.7 COVID-19 Impact: Pediatric Craniosynostosis Treatment Market Trends
2 Global Pediatric Craniosynostosis Treatment Quarterly Market Size Analysis
2.1 Pediatric Craniosynostosis Treatment Business Impact Assessment - COVID-19
2.1.1 Global Pediatric Craniosynostosis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Pediatric Craniosynostosis Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Pediatric Craniosynostosis Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Pediatric Craniosynostosis Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Pediatric Craniosynostosis Treatment Market
3.4 Key Players Pediatric Craniosynostosis Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Pediatric Craniosynostosis Treatment Segments, By Type
4.1 Introduction
1.4.1 Stereotactic Image Guided Endoscopic Craniosynostosis Repair
1.4.2 Standard Craniosynostosis Surgery
1.4.3 Baby Helmet Therapy
4.2 By Type, Global Pediatric Craniosynostosis Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Pediatric Craniosynostosis Treatment Segments, By Application
5.1 Overview
5.5.1 Hospital
5.5.2 Clinics
5.5.3 Diagnostic Centers
5.2 By Application, Global Pediatric Craniosynostosis Treatment Market Size, 2019-2021
5.2.1 By Application, Global Pediatric Craniosynostosis Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Arthrex
7.1.1 Arthrex Business Overview
7.1.2 Arthrex Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.1.3 Arthrex Pediatric Craniosynostosis Treatment Product Introduction
7.1.4 Arthrex Response to COVID-19 and Related Developments
7.2 B. Braun Melsungen
7.2.1 B. Braun Melsungen Business Overview
7.2.2 B. Braun Melsungen Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.2.3 B. Braun Melsungen Pediatric Craniosynostosis Treatment Product Introduction
7.2.4 B. Braun Melsungen Response to COVID-19 and Related Developments
7.3 Cogentix Medical
7.3.1 Cogentix Medical Business Overview
7.3.2 Cogentix Medical Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.3.3 Cogentix Medical Pediatric Craniosynostosis Treatment Product Introduction
7.3.4 Cogentix Medical Response to COVID-19 and Related Developments
7.4 Medtronic
7.4.1 Medtronic Business Overview
7.4.2 Medtronic Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.4.3 Medtronic Pediatric Craniosynostosis Treatment Product Introduction
7.4.4 Medtronic Response to COVID-19 and Related Developments
7.5 Conmed Corporation
7.5.1 Conmed Corporation Business Overview
7.5.2 Conmed Corporation Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.5.3 Conmed Corporation Pediatric Craniosynostosis Treatment Product Introduction
7.5.4 Conmed Corporation Response to COVID-19 and Related Developments
7.6 Cook Medical
7.6.1 Cook Medical Business Overview
7.6.2 Cook Medical Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.6.3 Cook Medical Pediatric Craniosynostosis Treatment Product Introduction
7.6.4 Cook Medical Response to COVID-19 and Related Developments
7.7 Johnson & Johnson Services
7.7.1 Johnson & Johnson Services Business Overview
7.7.2 Johnson & Johnson Services Pediatric Craniosynostosis Treatment Quarterly Revenue, 2020
7.7.3 Johnson & Johnson Services Pediatric Craniosynostosis Treatment Product Introduction
7.7.4 Johnson & Johnson Services Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
